PubMed · 2009 · 124 citations · 15 references
Life SciencesImmunologyPathologyApoptosisAutoimmunityImmunopathologyApoptosis In Immune CellsAutoimmune Disease DiagnosticsAutoimmune Disease PathogenesisAutoimmune Disease PathologyAutoimmune DiseasesAutoimmune Hematologic DiseaseApoptosis In Autoimmune DiseaseCell Death DetectionFas LigandFas Ligand-mediated ApoptosisT-cell Biomarkers
Autoimmune lymphoproliferative syndrome (ALPS) is characterized by splenomegaly, lymphadenopathy, hypergammaglobulinemia, accumulation of double-negative TCRalphabeta(+) CD4(-)CD8(-) T cells (DNT cells), and autoimmunity. Previously, DNT cell detection and a functional defect of T cells in a FAS-induced apoptosis test in vitro had been used for ALPS diagnosis. However, a functional defect can also be detected in mutation-positive relatives (MPRs) who remain free of any ALPS-related disease. In contrast, lymphocytes from patients carrying a somatic mutation of FAS exhibit normal sensitivity to FAS-induced apoptosis in vitro. We assessed the soluble FAS-L concentration in the plasma of ALPS patients carrying FAS mutations. Overall, we showed that determination of the FAS-L represents, together with the IL-10 concentration and the DNT cell percentage, a reliable tool for the diagnosis of ALPS.
15
Mutations in Fas Associated with Human Lymphoproliferative Syndrome and Autoimmunity
Frédéric Rieux‐Laucat, Françoise Le Deist, Claire Hivroz et al. · Science · 1995 · 1.3K citations
Life Sciences, Immunology, Pathology +17